Human medicines European public assessment report (EPAR): Atriance, nelarabine, Date of authorisation: 22/08/2007, Revision: 30, Status: Authorised

16 April 2026

Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 9, Status: Authorised

16 April 2026

Recommendations on medication errors

16 April 2026

Minutes - HMA-EMA joint Network Data Steering Group meeting - 9 March 2026

16 April 2026

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - September 2026, Online, from 10 September 2026, 15:00 (CEST) to 10 September 2026, 16:00 (CEST)

16 April 2026

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - October 2026, Online, from 8 October 2026, 15:00 (CEST) to 8 October 2026, 16:00 (CEST)

16 April 2026

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - November 2026, Online, from 12 November 2026, 15:00 (CET) to 12 November 2026, 16:00 (CET)

16 April 2026

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - December 2026, Online, from 10 December 2026, 15:00 (CET) to 10 December 2026, 16:00 (CET)

16 April 2026

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - June 2026, Online, from 11 June 2026, 15:00 (CEST) to 11 June 2026, 16:00 (CEST)

16 April 2026

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - July 2026, Online, from 9 July 2026, 15:00 (CEST) to 9 July 2026, 16:00 (CEST)

16 April 2026